Search Results - "Weinshenker, Brian G."

Refine Results
  1. 1

    Neuromyelitis Spectrum Disorders by Weinshenker, Brian G., MD, Wingerchuk, Dean M., MD

    Published in Mayo Clinic proceedings (01-04-2017)
    “…Abstract The understanding of neuromyelitis optica spectrum disorder (NMOSD) has evolved substantially since its initial description over a century ago. The…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events by Kunchok, Amy, Aksamit, Jr, Allen J, Davis, 3rd, John M, Kantarci, Orhun H, Keegan, B Mark, Pittock, Sean J, Weinshenker, Brian G, McKeon, Andrew

    Published in JAMA neurology (01-08-2020)
    “…Tumor necrosis factor (TNF) inhibitors are common therapies for certain autoimmune diseases, such as rheumatoid arthritis. An association between TNF inhibitor…”
    Get more information
    Journal Article
  6. 6

    The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease by Wingerchuk, Dean M, Weinshenker, Brian G

    Published in Multiple sclerosis (01-01-2012)
    “…Neuromyelitis optica (NMO) and NMO spectrum disorders (NMOSD) are associated with autoantibodies that target aquaporin-4 and, in many cases, multiple other…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Atypical inflammatory demyelinating syndromes of the CNS by Hardy, Todd A, Dr, Reddel, Stephen W, PhD, Barnett, Michael H, PhD, Palace, Jacqueline, DM, Lucchinetti, Claudia F, Prof, Weinshenker, Brian G, Prof

    Published in Lancet neurology (01-08-2016)
    “…Summary Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor…”
    Get full text
    Journal Article
  9. 9

    Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study by Pittock, Sean J, Dr, Lennon, Vanda A, PhD, McKeon, Andrew, MD, Mandrekar, Jay, PhD, Weinshenker, Brian G, MD, Lucchinetti, Claudia F, MD, O'Toole, Orna, MD, Wingerchuk, Dean M, Dr

    Published in Lancet neurology (01-06-2013)
    “…Summary Background Complement activation after binding of an IgG autoantibody to aquaporin 4 (AQP4) is thought to be a major determinant of CNS inflammation…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Discriminating long myelitis of neuromyelitis optica from sarcoidosis by Flanagan, Eoin P., Kaufmann, Timothy J., Krecke, Karl N., Aksamit, Allen J., Pittock, Sean J., Keegan, B. Mark, Giannini, Caterina, Weinshenker, Brian G.

    Published in Annals of neurology (01-03-2016)
    “…Objective To compare longitudinally extensive myelitis in neuromyelitis optica spectrum disorders (NMOSD) and spinal cord sarcoidosis (SCS). Methods We…”
    Get full text
    Journal Article
  13. 13

    Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders by Flanagan, Eoin P, Weinshenker, Brian G, Krecke, Karl N, Lennon, Vanda A, Lucchinetti, Claudia F, McKeon, Andrew, Wingerchuk, Dean M, Shuster, Elizabeth A, Jiao, Yujuan, Horta, Erika S, Pittock, Sean J

    Published in JAMA neurology (01-01-2015)
    “…Short transverse myelitis (STM; <3 vertebral segments) is considered noncharacteristic of neuromyelitis optica (NMO) spectrum disorders (NMOSDs)…”
    Get more information
    Journal Article
  14. 14
  15. 15

    The spectrum of neuromyelitis optica by Wingerchuk, Dean M, MD, Lennon, Vanda A, PhD, Lucchinetti, Claudia F, MD, Pittock, Sean J, MD, Weinshenker, Brian G, MD

    Published in Lancet neurology (01-09-2007)
    “…Summary Neuromyelitis optica (also known as Devic's disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially…”
    Get full text
    Journal Article
  16. 16

    Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica by Jiao, Yujuan, Fryer, James P., Lennon, Vanda A., Jenkins, Sarah M., Quek, Amy M.L., Smith, Carin Y., McKeon, Andrew, Costanzi, Chiara, Iorio, Raffaele, Weinshenker, Brian G., Wingerchuk, Dean M., Shuster, Elizabeth A., Lucchinetti, Claudia F., Pittock, Sean J.

    Published in Neurology (01-10-2013)
    “…OBJECTIVE:To 1) determine, using contemporary recombinant antigen–based assays, the aquaporin-4 (AQP4)–immunoglobulin G (IgG) detection rate in sequential sera…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis by Lennon, Vanda A, Wingerchuk, Dean M, Kryzer, Thomas J, Pittock, Sean J, Lucchinetti, Claudia F, Fujihara, Kazuo, Nakashima, Ichiro, Weinshenker, Brian G

    Published in The Lancet (British edition) (11-12-2004)
    “…Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is…”
    Get full text
    Journal Article
  20. 20

    Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology by Sechi, Elia, Shosha, Eslam, Williams, Jonathan P, Pittock, Sean J, Weinshenker, Brian G, Keegan, B Mark, Zalewski, Nicholas L, Lopez-Chiriboga, Alfonso Sebastian, Jitprapaikulsan, Jiraporn, Flanagan, Eoin P

    Published in Neurology (23-07-2019)
    “…OBJECTIVEDiagnostic criteria from 2002 classify transverse myelitis (TM) as idiopathic or disease associated but predate the discovery of aquaporin-4…”
    Get full text
    Journal Article